National Institute on Drug Abuse; Notice of Closed Meeting, 37234 [2017-16733]
Download as PDF
37234
Federal Register / Vol. 82, No. 152 / Wednesday, August 9, 2017 / Notices
Medicare Access and CHIP
Reauthorization Act of 2015, 42 U.S.C
1395ee. This Committee is also
governed by provisions of the Federal
Advisory Committee Act, as amended (5
U.S.C App.), which sets forth standards
for the formation and use of federal
advisory committees. In accordance
with its statutory mandate, the
Committee is to review physicianfocused payment model proposals and
prepare recommendations regarding
whether such models meet criteria that
were established through rulemaking by
the Secretary of Health and Human
Services (the Secretary). The Committee
is composed of 11 members appointed
by the Comptroller General.
II. Agenda
At the September 7–8, 2017, the
Committee will hear presentations on
PFPMs that are ready for Committee
deliberation. The presentations will be
followed by public comment and
Committee deliberation. If the
Committee completes deliberations,
voting will occur on recommendations
to the Secretary of Health and Human
Services. There will be time allocated
for public comment on agenda items.
Documents will be posted on the
Committee Web site and distributed on
the Committee listserv prior to the
public meeting. The agenda is subject to
change. If the agenda does change, we
will inform registrants and update our
Web site to reflect any changes.
III. Meeting Attendance
The meeting is open to the public.
The public may also attend via
conference call or view the meeting via
livestream at www.hhs.gov/live. The
conference call dial-in information will
be sent to registrants prior to the
meeting.
sradovich on DSK3GMQ082PROD with NOTICES
Meeting Registration
The public may attend the meetings
in-person or participate by phone via
audio teleconference. Space is limited
and registration is preferred in order to
attend in-person or by phone.
Registration may be completed online at
www.regonline.com/PTACMeetings
Registration.
The following information is
submitted when registering:
Name:
Company/organization name:
Postal address:
Email address:
Persons wishing to attend this
meeting must register by following the
instructions in the ‘‘Meeting
Registration’’ section of this notice. A
confirmation email will be sent to
VerDate Sep<11>2014
17:00 Aug 08, 2017
Jkt 241001
registrants shortly after completing the
registration process.
IV. Special Accommodations
If sign language interpretation or other
reasonable accommodation for a
disability is needed, please contact
Angela Tejeda, no later than August 24,
2017. Please submit your requests by
email to Angela.Tejeda@hhs.gov or by
calling 202–401–8297.
V. Copies of the PTAC Charter and
Meeting Material
The Secretary’s Charter for the
Physician-Focused Payment Model
Technical Advisory Committee is
available on the ASPE Web site at
https://aspe.hhs.gov/charter-physicianfocused-payment-model-technicaladvisory-committee.
Additional material for this meeting
can be found on the PTAC Web site. For
updates and announcements, please use
the link to subscribe to the PTAC email
listserv.
Dated: August 3, 2017.
John R. Graham,
Acting Assistant Secretary for Planning and
Evaluation.
[FR Doc. 2017–16784 Filed 8–8–17; 8:45 am]
BILLING CODE 4150–05–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
Informatics Support for NIDA (8940).
Date: August 31, 2017.
Time: 9:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Hilton Garden Inn Bethesda, 7301
Waverly Street, Bethesda, MD 20814.
Contact Person: Lyle Furr, Scientific
Review Officer, Office of Extramural Affairs,
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
National Institute on Drug Abuse, NIH,
DHHS, Room 4227, MSC 9550, 6001
Executive Boulevard, Bethesda, MD 20892–
9550, (301) 827–5702, lf33c.nih.gov.
(Catalogue of Federal Domestic Assistance
Program No.: 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS)
Dated: August 3, 2017.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–16733 Filed 8–8–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, RFA–MH–
17–650: Implementation Science for the
Prevention and Treatment of Mental and/or
Substance Use Disorders in Low- and
Middle-income Countries (U01).
Date: September 4–5, 2017.
Time: 8:00 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: President Hotel, 4 Alexander Road,
Bantry Bay, Cape Town, 8001, South Africa.
Contact Person: Seetha Bhagavan, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5194,
MSC 7846, Bethesda, MD 20892, (301) 237–
9838, bhagavas@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, PAR–17–
076: High-End Instrumentation (HEI) Grant
Program (S10).
Date: September 12, 2017.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Ritz-Carlton Hotel at Pentagon City,
1250 South Hayes Street, Arlington, VA
22202.
Contact Person: Songtao Liu, MD,
Scientific Review Officer, Center for
E:\FR\FM\09AUN1.SGM
09AUN1
Agencies
[Federal Register Volume 82, Number 152 (Wednesday, August 9, 2017)]
[Notices]
[Page 37234]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-16733]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The contract proposals and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; Informatics Support for NIDA (8940).
Date: August 31, 2017.
Time: 9:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: Hilton Garden Inn Bethesda, 7301 Waverly Street,
Bethesda, MD 20814.
Contact Person: Lyle Furr, Scientific Review Officer, Office of
Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS,
Room 4227, MSC 9550, 6001 Executive Boulevard, Bethesda, MD 20892-
9550, (301) 827-5702, lf33c.nih.gov.
(Catalogue of Federal Domestic Assistance Program No.: 93.279, Drug
Abuse and Addiction Research Programs, National Institutes of
Health, HHS)
Dated: August 3, 2017.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-16733 Filed 8-8-17; 8:45 am]
BILLING CODE 4140-01-P